DnB Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
DnB Asset Management's TVTX Position: Q3 2026 in Review
DnB Asset Management opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 3,952 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1091 among its holdings.
345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- DnB Asset Management held 3,952 shares of Travere Therapeutics worth $233K as of Q3 2026.
- Travere Therapeutics was a new DnB Asset Management position in Q3 2026.
- Travere Therapeutics made up ﹤0.01% of DnB Asset Management's portfolio in Q3 2026, its #1091 holding.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on DnB Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.